IPO activity: The six-month lockup on shares of
Nio (NYSE:NIO) expires on March 11 in what should be a good test of investor sentiment. Nio soared following a positive 60 Minutes piece about two weeks ago before going into post-earnings skid. Interestingly, Goldman Sachs came in with a reinstated Buy call on Nio ahead of the lockup expiration as it pointed to the Chinese automaker's "successful branding" in the premium segment.
Other lockup expirations this week include;
- 111 (NASDAQ:YI) on March 11,
- FVC Bancorp (NASDAQ:FVCB) on March 12 and
- both Principia Biopharma (NASDAQ:PRNB) and Qutoutiao (NASDAQ:QTT) on March 13.
Analysts can start covering TCR2 Therapeutics (NASDAQ:
TCRR), Avedro (NASDAQ:
AVDR), Achiano Therapeutics (NASDAQ:
ANCN) and Imac (NASDAQ:
IMAC) on March 11 and Stealth BioTherapeutics (NASDAQ:
MITO) on March 12.
No comments:
Post a Comment